Molecular determinants that mediate selective activation of p38 MAP kinase isoforms

被引:187
|
作者
Enslen, H
Brancho, DM
Davis, RJ [1 ]
机构
[1] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA
来源
EMBO JOURNAL | 2000年 / 19卷 / 06期
关键词
MAP kinase; MKK3; MKK6; p38; signal transduction;
D O I
10.1093/emboj/19.6.1301
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p38 mitogen-activated protein kinase (MAPK) group is represented by four isoforms in mammals (p38 alpha, p38 beta 2, p38 gamma and p38 delta), These p38 MAPK isoforms appear to mediate distinct functions in vivo due, in part, to differences in substrate phosphorylation by individual p38 MAPKs and also to selective activation by MAPK kinases (MAPKKs), Here we report the identification of two factors that contribute to the specificity of p38 MAPK activation. One mechanism of specificity is the selective formation of functional complexes between MAPKK and different p38 MAPKs, The formation of these complexes requires the presence of a MAPK docking site in the N-terminus of the MAPKK. The second mechanism that confers signaling specificity is the selective recognition of the activation loop (T-loop) of p38 MAPK isoforms. Together, these processes provide a mechanism that enables the selective activation of p38 MAPK in response to activated MAPKK.
引用
收藏
页码:1301 / 1311
页数:11
相关论文
共 50 条
  • [21] Potent inhibitors of the map kinase p38
    Henry, JR
    Rupert, KC
    Dodd, JH
    Turchi, IJ
    Wadsworth, SA
    Cavender, DE
    Schafer, PH
    Siekierka, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3335 - 3340
  • [22] Kinetic mechanism for p38 MAP kinase
    LoGrasso, PV
    Frantz, B
    Rolando, AM
    OKeefe, SJ
    Hermes, JD
    ONeill, EA
    BIOCHEMISTRY, 1997, 36 (34) : 10422 - 10427
  • [23] The development p38 MAP kinase inhibitors
    Hynes, John
    Wu, H.
    Dyckman, A. J.
    Lin, S.
    Wrobleski, S. T.
    Gillooly, K. M.
    McIntyre, K. W.
    Pitt, S.
    Shen, D. R.
    Shuster, D. J.
    Xia, X.
    Zhang, R.
    INFLAMMATION RESEARCH, 2007, 56 : S474 - S474
  • [24] Inhibitors of unactivated p38 MAP kinase
    Bullington, James
    Argentieri, Dennis
    Averill, Kristin
    Carter, Demetrius
    Cavender, Druie
    Fahmy, Bohumila
    Fan, Xiaodong
    Hall, Daniel
    Heintzelman, Geoffrey
    Jackson, Paul
    Leung, Wai-Ping
    Li, Xun
    Ling, Ping
    Olini, Gilbert
    Razler, Thomas
    Reuman, Michael
    Rupert, Kenneth
    Russell, Ronald
    Siekierka, John
    Wadsworth, Scott
    Wolff, Russell
    Xiang, Bangping
    Zhang, Yue-Mei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6102 - 6106
  • [25] Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation
    Kuliopulos, A
    Mohanlal, R
    Covic, L
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) : 1387 - 1393
  • [26] Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase
    Cumming, JG
    McKenzie, CL
    Bowden, SG
    Campbell, D
    Masters, DJ
    Breed, J
    Jewsbury, PJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5389 - 5394
  • [27] Selective activation of p38 MAPK isoforms p38α and p38δ by TGF-β1 is mediated via mitogen-activated protein kinase kinase 3 (MKK3) in mouse mesangial cells.
    Wang, L
    Zheng, XJ
    Ma, R
    Choi, ME
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 15A - 16A
  • [28] Role of CaMKII in nicotine-induced p38 map kinase activation
    Kajiwara, Aya
    Tsuchiya, Yukihiro
    Ihara, Hideshi
    Watanabe, Yasuo
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2012, 27 : S11 - S11
  • [29] Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib
    Dumka, Disha
    Puri, Poonam
    Carayol, Nathalie
    Lumby, Crystal
    Balachandran, Harikrishnan
    Schuster, Katja
    Verma, Amit K.
    Terada, Lance S.
    Platanias, Leonidas C.
    Parmar, Simrit
    LEUKEMIA & LYMPHOMA, 2009, 50 (12) : 2017 - 2029
  • [30] A role for p38 MAP kinase in platelet activation by von Willebrand factor
    Canobbio, I
    Reineri, S
    Sinigaglia, F
    Balduini, C
    Torti, M
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (01) : 102 - 110